HIN-1, an Inhibitor of Cell Growth, Invasion, and AKT Activation

Ian E. Krop(Yale Cancer Center), Kornélia Polyák(Dana-Farber Cancer Institute), Michele Taylor Parker(Harvard University), Rebecca Gelman(Dana-Farber Cancer Institute), Mary Beth Terry(Columbia University Irving Medical Center), Ramon Parsons(Icahn School of Medicine at Mount Sinai), Hidefumi Sasaki(Broad Institute), Noga Bloushtain-Qimron(Dana-Farber Cancer Institute), Matthew Maurer(NewYork–Presbyterian Hospital), Dale Porter
Cancer Research
November 1, 2005
10.1158/0008-5472.can-05-1663
Cited by 65

Related Papers

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
|Cell|2008|8.7k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Next-generation characterization of the Cancer Cell Line Encyclopedia
|Nature|2019|3.7k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k